Endpoints News
At-home screening startup Reperio raises $14M Read in browser
Endpoints News
Tuesday, 20 May 2025
Thank you for reading, dupa dupackia!
basic
UPGRADE
Investments in women's health reach
SVB Report: Women’s health biopharma investments triple in 3 years
sponsored by Silicon Valley Bank
Shutting down a startup
In one of the most comprehensive and candid post-mortems on a health startup I’ve read, Duncan Reece wrote about why he shuttered the dementia care startup, called Veronica Health, he’d been building quietly for the past couple of years. I caught up with him to learn more about his decision.
Veronica was built on the idea that combining clinical support for the patient with resources, tools and services for family caregivers could produce better outcomes and lower the cost of care for dementia patients. 
The startup’s plan was to take that concept to community practices and scale it. Veronica would have a dementia specialist, but a lot of work would be done by social workers who would check on patients with a primary care doctor. It would get paid by Medicare Advantage plans — and they were indeed interested in the model after Veronica opened their eyes to the invisible costs of dementia, Reece told me.
The concept sounds like a winning one. I lived with my grandmother, who has dementia, for a year in 2023 and it was tough. I can only imagine how helpful caregiving support would have been for me and my family.
But Reece ultimately shut Veronica down before it ever started seeing patients. The team had set out to raise about $9 million, and it didn’t happen. That was in part because investors are skeptical of value-based health services companies, many of which have struggled or have yet to prove themselves, Reece said.
Plus, fundraising doesn’t come with a how-to manual. Reece, who co-founded Cohere Health, hadn’t led a fundraising round before. He said he could have moved faster with more confidence and made it clear that he was going to be the CEO. Investors need to feel like they’re in competition for you and your company, he said. 
“You only have so many shots on goal when you run a financing process,” he said. “It’s important to be super organized, run a tight process, and make it super easy for investors to lean in and want to write you a check.”
There’s debate over whether venture-backed, tech-enabled health services startups can work. Services companies tend to require a ton of time and capital to get to scale, and their returns may not be as lofty as VCs want to see. But Reece has no doubt Veronica could have succeeded if he hadn’t made certain mistakes. It had a customer base, clinical credibility, and evidence for a business model — key ingredients he said are necessary for a startup.
Reece was angry when Veronica first closed. But he chose to share his experience because he wants other people to learn from his missteps and try tackling this dementia care problem. 
“We need more open sourcing of what we learned, so folks have a better shot of making it," he said.
Reece is already working on his next startup, which will use AI to help doctors do the work they set out to do when they went to medical school, he said.
- Shelby
--
P.S. - This newsletter just won a Jesse H. Neal award for Best e-newsletter! It’s really exciting to see the work we’ve done get recognized twice now — in less than two years since we launched. Thanks so much for being here (and hey, if you think you know anyone who would benefit from a little health tech news and analysis, be sure to have them subscribe here as well!). It’s what makes this newsletter great.
Here’s what’s new
Exclusive: Weight loss startup Calibrate swaps CEOs in latest leadership shakeup
Cal­i­brate has re­placed its CEO and made sev­er­al oth­er ex­ec­u­tive changes, End­points News has learned, the lat­est lead­er­ship re­set at the once high-fly­ing weight loss com­pa­ny.
Why Regeneron is buying 23andMe
Re­gen­eron is dou­bling down on its ge­net­ics re­search am­bi­tions by agree­ing to buy most of 23andMe’s busi­ness out of bank­rupt­cy.
Exclusive: At-home screening startup Reperio Health raises $14M
Tele­health is be­com­ing more com­pre­hen­sive than a quick on­line vis­it.
Exclusive: Optura raises $6.5M to help evaluate healthcare AI programs
Health­care is fig­ur­ing out what AI to use in a crowd­ed mar­ket. Op­tura says it can help tell you if what you are try­ing is worth it.
UnitedHealth’s steep drop
An image of UnitedHealth Group's stock price over the past 6 months.
UnitedHealth Group’s stock has fallen precipitously, dipping by about 50% from April 16 to May 16. The healthcare giant faces reported criminal and civil investigations, and its CEO Andrew Witty stepped down last week. The company pulled its 2025 guidance as well.
This week in health Тech
Akido raised $60 million in a Series B round led by Oak HC/FT, bringing its total funding to $100 million to date. As Shelby covered, the startup is letting AI run medical visits, helping with everything from intake to diagnosis.
Sprinter Health, a startup providing in-home and virtual care, raised $55 million. General Catalyst led the Series B round.
MIT Technology Review has a closer look at Montana, whose legislature recently passed a bill paving a way for experimental medical treatments to be used in the state if they’ve passed a Phase 1 trial. Longevity enthusiasts lobbied for the bill, with the hopes of trying anti-aging treatments that haven’t gone through the FDA approval process.
Whole-body imaging company Prenuvo hired Jill Woodworth as its CFO. During her time as Peloton’s CFO, Woodworth saw the company through its IPO.
John Carroll
Editor & Founder
Arsalan Arif
Publisher & Founder
Igor Yavych
Architect & Founder
Valentin Manov
Creative Director
Ryan McRae
Chief Revenue Officer
Amanda Florez
Chief of Staff
Drew Armstrong
Executive Editor
Liam Chua
Chief Technical Officer
Jaimy Lee
Deputy Editor
Lydia R. Pflanzer
Deputy Editor